Jeanette H.W. Leusen

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

The Effect of Radiation Treatment of Solid Tumors on Neutrophil Infiltration and Function: A Systematic Review

IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models

Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial

Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy

The selection of variable regions affects effector mechanisms of IgA antibodies against CD20

γ9δ2T cell diversity and the receptor interface with tumor cells

ARGX-117, a therapeutic complement inhibiting antibody targeting C2

Identification of a tumor-specific allo-HLA–restricted γδTCR

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness

Human IgG1 antibodies suppress angiogenesis in a target-independent manner

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk

FcRγ-Chain ITAM Signaling Is Critically Required for Cross-Presentation of Soluble Antibody–Antigen Complexes by Dendritic Cells

Fc  receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy

<i>Staphylococcus aureus</i> Formyl Peptide Receptor–like 1 Inhibitor (FLIPr) and Its Homologue FLIPr-like Are Potent FcγR Antagonists That Inhibit IgG-Mediated Effector Functions

IgG Antibodies in Food Allergy Influence Allergen–Antibody Complex Formation and Binding to B Cells: A Role for Complement Receptors

Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2 m(1) antibody

Mechanisms of action of CD20 antibodies.

Crosstalk between Human IgG Isotypes and Murine Effector Cells